KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q1 2022?

84 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 50,580,036
Total 13F shares: 23,950,478
Share change: -1,023,340
Total reported value: $353,046,504
Put/Call ratio: 0%
Price per share: $14.74
Number of holders: 84
Value change: -$11,733,222
Number of buys: 38
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.8%	1,930,322	$25,538,000	—	31 Dec 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.6%	1,811,505	$23,966,000	—	31 Dec 2021	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	3.5%	1,746,300	$23,104,000	—	31 Dec 2021	13F
Vivo Capital, LLC	13F	Company	3%	1,533,559	$20,289,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	3%	1,504,620	$19,906,000	—	31 Dec 2021	13F
Deep Track Capital, LP	13F	Company	3%	1,500,000	$19,845,000	—	31 Dec 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	2.6%	1,305,087	$17,266,000	—	31 Dec 2021	13F
FRANKLIN RESOURCES INC	13F	Company	2.5%	1,252,142	$16,565,000	—	31 Dec 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.3%	1,175,131	$15,547,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	2.3%	1,138,484	$15,062,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	2.1%	1,051,976	$13,918,000	—	31 Dec 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.7%	884,339	$11,700,000	—	31 Dec 2021	13F
FMR LLC	13F	Company	1.6%	787,220	$10,415,000	—	31 Dec 2021	13F
Laurion Capital Management LP	13F	Company	0.93%	470,000	$6,218,000	—	31 Dec 2021	13F
GREAT POINT PARTNERS LLC	13F	Company	0.81%	411,937	$5,450,000	—	31 Dec 2021	13F
Prosight Management, LP	13F	Company	0.81%	409,620	$5,419,000	—	31 Dec 2021	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.76%	383,233	$5,066,000	—	31 Dec 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.75%	379,233	$5,017,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.75%	377,970	$5,000,000	—	31 Dec 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.63%	316,200	$4,183,000	—	31 Dec 2021	13F
Commodore Capital LP	13F	Company	0.62%	312,553	$4,135,000	—	31 Dec 2021	13F
Monashee Investment Management LLC	13F	Company	0.59%	300,000	$3,969,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.5%	254,909	$3,372,000	—	31 Dec 2021	13F
DAFNA Capital Management LLC	13F	Company	0.38%	190,663	$2,522,000	—	31 Dec 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.33%	168,331	$2,227,000	—	31 Dec 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.27%	138,821	$1,837,000	—	31 Dec 2021	13F
Woodline Partners LP	13F	Company	0.27%	138,738	$1,836,000	—	31 Dec 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.23%	115,122	$1,523,000	—	31 Dec 2021	13F
Altium Capital Management LLC	13F	Company	0.22%	111,834	$1,480,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	99,431	$1,315,000	—	31 Dec 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.19%	97,592	$1,291,000	—	31 Dec 2021	13F
MANGROVE PARTNERS IM, LLC	13F	Company	0.18%	92,000	$1,217,000	—	31 Dec 2021	13F
Nan Fung Group Holdings Ltd	13F	Company	0.16%	78,720	$1,041,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.13%	67,351	$891,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.13%	65,732	$870,000	—	31 Dec 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.13%	64,186	$849,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.12%	63,084	$835,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.12%	63,100	$796,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	57,415	$760,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0.11%	54,127	$716,000	—	31 Dec 2021	13F
UBS Group AG	13F	Company	0.11%	53,563	$708,000	—	31 Dec 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.08%	41,087	$544,000	—	31 Dec 2021	13F
Birchview Capital, LP	13F	Company	0.08%	40,000	$529,000	—	31 Dec 2021	13F
Ikarian Capital, LLC	13F	Company	0.07%	36,576	$484,000	—	31 Dec 2021	13F
CSS LLC/IL	13F	Company	0.07%	34,999	$463,000	—	31 Dec 2021	13F
FIRST TRUST ADVISORS LP	13F	Company	0.07%	33,696	$446,000	—	31 Dec 2021	13F
Tekla Capital Management LLC	13F	Company	0.06%	31,594	$418,000	—	31 Dec 2021	13F
APOGEM CAPITAL LLC	13F	Company	0.06%	30,763	$407,000	—	31 Dec 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.06%	30,423	$402,000	—	31 Dec 2021	13F
BARCLAYS PLC	13F	Company	0.06%	28,986	$383,000	—	31 Dec 2021	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2022

As of 31 Mar 2022, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,950,478 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., BlackRock Inc., Vivo Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, and STATE STREET CORP. This page lists 84 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q1 2022 holders

Holder diff

-9

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.